Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-((phenylacetyl)amino)-2,6-piperidinedione
2. 3-(n-phenylacetylamino)-2,6-piperidinedione
3. A 10
4. A-10
5. A10
6. Antineoplaston-a10
7. N-(2,6-dioxo-3-piperidinyl)benzeneacetamide
1. 91531-30-5
2. Antineoplaston A 10
3. N-[(3s)-2,6-dioxopiperidin-3-yl]-2-phenylacetamide
4. Atengenal
5. 16vy3tm7zo
6. Antineoplaston A-10
7. A-10
8. Antineoplaston-a10
9. Benzeneacetamide, N-(2,6-dioxo-3-piperidinyl)-, (s)-
10. A 10
11. Unii-16vy3tm7zo
12. Cengenal
13. 3-(n-phenylacetylamino)-2,6-piperidinedione
14. N-(2,6-dioxo-3-piperidinyl)benzeneacetamide
15. 3-((phenylacetyl)amino)-2,6-piperidinedione
16. Antineoplastona10
17. Antineoplaston A10 Capsules
18. Anp-a10
19. A10
20. Chembl1980825
21. Schembl20772654
22. Dtxsid00919683
23. Zinc1590366
24. Mfcd26961095
25. Nsc619130
26. N-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2-phenylethanimidic Acid
27. Antineoplaston A 10 [who-dd]
28. Db11702
29. Nsc-619130
30. As-84380
31. Nci60_005691
32. Hy-128553
33. Cs-0095862
34. D80851
35. (s)-n-(2,6-dioxopiperidin-3-yl)-2-phenylacetamide
36. N-[(3s)-2,6-dioxo-3-piperidyl]-2-phenyl-acetamide
37. Q27251844
38. Benzeneacetamide, N-((3s)-2,6-dioxo-3-piperidinyl)-
| Molecular Weight | 246.26 g/mol |
|---|---|
| Molecular Formula | C13H14N2O3 |
| XLogP3 | 0.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 246.10044231 g/mol |
| Monoisotopic Mass | 246.10044231 g/mol |
| Topological Polar Surface Area | 75.3 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 348 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Antineoplaston A10 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antineoplaston A10, including repackagers and relabelers. The FDA regulates Antineoplaston A10 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antineoplaston A10 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Antineoplaston A10 supplier is an individual or a company that provides Antineoplaston A10 active pharmaceutical ingredient (API) or Antineoplaston A10 finished formulations upon request. The Antineoplaston A10 suppliers may include Antineoplaston A10 API manufacturers, exporters, distributors and traders.
click here to find a list of Antineoplaston A10 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Antineoplaston A10 DMF (Drug Master File) is a document detailing the whole manufacturing process of Antineoplaston A10 active pharmaceutical ingredient (API) in detail. Different forms of Antineoplaston A10 DMFs exist exist since differing nations have different regulations, such as Antineoplaston A10 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Antineoplaston A10 DMF submitted to regulatory agencies in the US is known as a USDMF. Antineoplaston A10 USDMF includes data on Antineoplaston A10's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Antineoplaston A10 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Antineoplaston A10 suppliers with USDMF on PharmaCompass.
Antineoplaston A10 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Antineoplaston A10 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Antineoplaston A10 GMP manufacturer or Antineoplaston A10 GMP API supplier for your needs.
A Antineoplaston A10 CoA (Certificate of Analysis) is a formal document that attests to Antineoplaston A10's compliance with Antineoplaston A10 specifications and serves as a tool for batch-level quality control.
Antineoplaston A10 CoA mostly includes findings from lab analyses of a specific batch. For each Antineoplaston A10 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Antineoplaston A10 may be tested according to a variety of international standards, such as European Pharmacopoeia (Antineoplaston A10 EP), Antineoplaston A10 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Antineoplaston A10 USP).
LOOKING FOR A SUPPLIER?
